External validation of models to predict the outcome of pregnancies of unknown location: a multicentre cohort study.
Adult
Calibration
Chorionic Gonadotropin, beta Subunit, Human
/ analysis
False Positive Reactions
Female
Humans
Predictive Value of Tests
Pregnancy
Pregnancy Tests
/ methods
Pregnancy, Ectopic
/ diagnosis
Prospective Studies
ROC Curve
Reproducibility of Results
Sensitivity and Specificity
Triage
/ methods
Beta human chorionic gonadotrophin ratio
ectopic pregnancy
prediction model
prediction model validation
pregnancy of unknown location
progesterone
Journal
BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
accepted:
28
08
2020
pubmed:
16
9
2020
medline:
20
1
2021
entrez:
15
9
2020
Statut:
ppublish
Résumé
To validate externally five approaches to predict ectopic pregnancy (EP) in pregnancies of unknown location (PUL): the M6P and M6NP risk models, the two-step triage strategy (2ST, which incorporates M6P), the M4 risk model, and beta human chorionic gonadotropin ratio cut-offs (BhCG-RC). Secondary analysis of a prospective cohort study. Eight UK early pregnancy assessment units. Women presenting with a PUL and BhCG >25 IU/l. Women were managed using the 2ST protocol: PUL were classified as low risk of EP if presenting progesterone ≤2 nmol/l; the remaining cases returned 2 days later for triage based on M6P. EP risk ≥5% was used to classify PUL as high risk. Missing values were imputed, and predictions for the five approaches were calculated post hoc. We meta-analysed centre-specific results. Discrimination, calibration and clinical utility (decision curve analysis) for predicting EP. Of 2899 eligible women, the primary analysis excluded 297 (10%) women who were lost to follow up. The area under the ROC curve for EP was 0.89 (95% CI 0.86-0.91) for M6P, 0.88 (0.86-0.90) for 2ST, 0.86 (0.83-0.88) for M6NP and 0.82 (0.78-0.85) for M4. Sensitivities for EP were 96% (M6P), 94% (2ST), 92% (N6NP), 80% (M4) and 58% (BhCG-RC); false-positive rates were 35%, 33%, 39%, 24% and 13%. M6P and 2ST had the best clinical utility and good overall calibration, with modest variability between centres. 2ST and M6P performed best for prediction and triage in PUL. The M6 model, as part of a two-step triage strategy, is the best approach to characterise and triage PULs.
Identifiants
pubmed: 32931087
doi: 10.1111/1471-0528.16497
pmc: PMC7821217
doi:
Substances chimiques
Chorionic Gonadotropin, beta Subunit, Human
0
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
552-562Subventions
Organisme : Research Foundation - Flanders
ID : G0B4716N
Pays : International
Organisme : Internal Funds KU Leuven
ID : C24/15/037
Pays : International
Organisme : NIHR CLAHRC NWL
ID : RDIP033
Pays : International
Organisme : NIHR Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London
Pays : International
Informations de copyright
© 2020 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.
Références
Ultrasound Obstet Gynecol. 2020 Jan;55(1):105-114
pubmed: 31385381
J Clin Epidemiol. 2016 Jun;74:167-76
pubmed: 26772608
Ultrasound Obstet Gynecol. 2007 Jun;29(6):680-7
pubmed: 17486691
Stat Med. 2012 Oct 15;31(23):2610-26
pubmed: 22733650
Hum Reprod Update. 2012 Nov-Dec;18(6):603-17
pubmed: 22956411
Eur Urol. 2018 Dec;74(6):796-804
pubmed: 30241973
BJOG. 2019 Jan;126(2):190-198
pubmed: 30129999
Hum Reprod. 2014 May;29(5):938-45
pubmed: 24634251
BJOG. 2017 Feb;124(3):423-432
pubmed: 27362778
Ultrasound Obstet Gynecol. 2016 Nov;48(5):642-649
pubmed: 26776599
Stat Med. 2018 May 30;37(12):2034-2052
pubmed: 29575170
Eur J Epidemiol. 2012 Oct;27(10):761-70
pubmed: 23054032
BMJ. 2012 Sep 27;345:e6077
pubmed: 23045257
BJOG. 2021 Feb;128(3):552-562
pubmed: 32931087
BJOG. 2011 May;118(6):693-7
pubmed: 21332634
BMC Med. 2015 Jan 06;13:1
pubmed: 25563062
Ultrasound Obstet Gynecol. 2009 Jun;33(6):704-10
pubmed: 19444818
Hum Reprod Update. 2014 Mar-Apr;20(2):250-61
pubmed: 24101604
Acta Obstet Gynecol Scand. 2008;87(11):1150-4
pubmed: 18846452
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
Hum Reprod. 2005 May;20(5):1404-9
pubmed: 15695311
Stat Med. 2016 Jan 30;35(2):214-26
pubmed: 26553135
Fertil Steril. 2011 Mar 1;95(3):857-66
pubmed: 20947073
Int J Gynaecol Obstet. 2004 Sep;86(3):351-7
pubmed: 15325852
Hum Reprod. 2013 Mar;28(3):609-16
pubmed: 23293216